WHO Prequalifies a Mpox Vaccine, Clearing Path to Access - Contagion Live
WHO prequalified MVA-BN as the first mpox vaccine, aiming to boost access and contain outbreaks. Bavarian Nordic plans to supply 10 million doses by 2025. The vaccine is 99.2% effective after two doses, according to CDC data.
Reference News
WHO Prequalifies a Mpox Vaccine, Clearing Path to Access - Contagion Live
WHO prequalified MVA-BN as the first mpox vaccine, aiming to boost access and contain outbreaks. Bavarian Nordic plans to supply 10 million doses by 2025. The vaccine is 99.2% effective after two doses, according to CDC data.